|Day Low/High||200.28 / 203.71|
|52 Wk Low/High||141.41 / 249.27|
As we noted earlier, the S&P 500 is having quite another year following its robust return in 2021. No doubt part of that is the sharp rebound in 2021 EPS expectations for the 500 companies that comprise that market benchmark, which also serves as a ...
ZTS is in a longer-term uptrend that should continue when the weakness in the broader market subsides.
There was a story almost entirely missed by the media on Wednesday. The Treasury Department announced a tapering of its own ahead of the Fed's policy statement.
Along with ZTS, we're taking a look at The Original BARK Co and Idexx Laboratories.
Imagine if the SEC did not prohibit underwriters from lending out shares to short-sellers for 30 days after an IPO?
Plus, we wait with great interest to learn what Berkshire Hathaway's holdings were as of the end of 2020.
Let's compare several dividend increases in time for the holidays -- and see who wins the 'derby.'
As pets have become an integral part of the family, people are willing to spend more on them.
Disney's trajectory could provide a blueprint for the reopening of travel and leisure -- and how investors react.
Let this animal medicine company go a bit lower before rounding up some shares.
Zoetis Inc. shares are up more than 45% year-to-date and the company appears on the path to becoming a Contender.
As for pressure on the Chinese side, I think a September 17.8% decline in exports to the U.S. compounded on top of a 22% decline in August speaks for itself.
Disney, Qualcomm and Square are among 75 key reports we are watching.
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
The uptrend that technicians would have confirmed as late as last Wednesday, or even Thursday around mid-day, is now clearly a market in correction.
The only effective way to deal with a bear market is to prepare for it ahead of time.
Let's check the charts of this animal health company.
Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
What about the technical story? Let's check out some charts.
Pets can bring significant profits to companies that cater to this niche market.
What trader has never both fallen in love with Nvidia, only to eventually feel the scorn of an angry lover's tortured vengeance?
Santa is on his way... A lot of pressure on the jolly fellow this year.
Straying from these names could land you in quicksand as the 4th quarter begins.
ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.
Let's take the charts and indicators for a walk and see how high they may go in the weeks ahead.
The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.